
Sign up to save your podcasts
Or


What are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey.
Credit available for this activity expires: 5/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001127?ecd=bdc_podcast_libsyn_mscpedu
By Medscape Podcasts4
77 ratings
What are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey.
Credit available for this activity expires: 5/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001127?ecd=bdc_podcast_libsyn_mscpedu

322 Listeners

498 Listeners

1,644 Listeners

880 Listeners

14 Listeners

16 Listeners

291 Listeners

3,354 Listeners

8,557 Listeners

191 Listeners

93 Listeners

514 Listeners

368 Listeners

61 Listeners

28 Listeners

426 Listeners

374 Listeners

29,246 Listeners

65 Listeners